No abstract available
MeSH terms
-
Antitubercular Agents / adverse effects*
-
Antitubercular Agents / pharmacokinetics
-
Arylamine N-Acetyltransferase / deficiency*
-
Arylamine N-Acetyltransferase / genetics*
-
Chemical and Drug Induced Liver Injury / enzymology*
-
Chemical and Drug Induced Liver Injury / genetics
-
Chemical and Drug Induced Liver Injury / pathology
-
Chemical and Drug Induced Liver Injury / surgery*
-
Female
-
Genes, MDR
-
Genetic Variation
-
Heterozygote
-
Humans
-
Isoniazid / adverse effects*
-
Isoniazid / pharmacokinetics
-
Liver Transplantation*
-
Middle Aged
-
Mutation
-
Risk Factors
Substances
-
Antitubercular Agents
-
Arylamine N-Acetyltransferase
-
NAT2 protein, human
-
Isoniazid